Martin Shkreli's Drug Company Had 'WTF' Moment When Reviewing Firm's 'Chaotic' Books | CNBC

"It was very difficult" to get information about Retrophin's financial statements from Martin Shkreli, an accountant said.
» Subscribe to CNBC: http://cnb.cx/SubscribeCNBC

About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.

Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Find CNBC News on Facebook: http://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: http://cnb.cx/FollowCNBC
Follow CNBC News on Google+: http://cnb.cx/PlusCNBC
Follow CNBC News on Instagram: http://cnb.cx/InstagramCNBC

Martin Shkreli's Drug Company Had 'WTF' Moment When Reviewing Firm's 'Chaotic' Books | CNBC



(Source: CNBC (via YouTube))